A Landmark Study Shows PALB2 Mutations Increase the Risk of Certain Cancers
In the largest study of people with inherited PALB2 mutations to date, the gene was linked to increased lifetime risk of breast cancer in women and men, ovarian and pancreatic cancer but not prostate or colorectal cancer.
In the largest study to date, 524 families with a PALB2 mutation were evaluated for their risk of breast, colorectal, ovarian, pancreatic and prostate cancers. Researchers saw an increased risk of breast cancer in both women and men, as well as increased risk of ovarian and pancreatic cancer. Risk of prostate or colorectal cancer was not increased in people with PALB2 mutations in this study. Knowledge of cancer risk can help people make more informed healthcare decisions. Read more in our XRAY review.
https://www.facingourrisk.org/XRAY/PALB2-cancer-risk?utm_source=CURE&utm_medium=website
Patient Advocate Faces Thyroid Cancer Decades After Surviving Breast Cancer
September 5th 2023‘I feel like I've gone to continuing education classes as an advocate through reentering the health system in the cancer space,’ FORCE executive director and founder Sue Friedman, a breast cancer survivor who recently received a diagnosis of thyroid cancer, tells CURE.
Read More
Stepping Up Again for Hereditary Cancer Prevention
February 25th 2023On Feb. 6, HB 2783 was introduced into the Arizona House. Hopefully this bill will help address some of the issues surrounding genetic testing, genetic counseling, and insurance coverage for those who might be at risk for hereditary cancer. My wife died of a cancer that was totally preventable. Nobody should die of a preventable cancer.
Read More
